Researchers are excited about this new drug, a novel dual agonist showing promising outcomes in clinical trials for weight reduction . It acts by modulating both pathways : GLP-1 and GIP, that , when https://theresaraos633176.blognody.com/49407752/the-new-hope-for-body-management